KR20010006393A - β-아밀로이드 펩타이드-결합 단백질 및 이를 암호화하는 폴리뉴클레오타이드 - Google Patents
β-아밀로이드 펩타이드-결합 단백질 및 이를 암호화하는 폴리뉴클레오타이드 Download PDFInfo
- Publication number
- KR20010006393A KR20010006393A KR1019997009480A KR19997009480A KR20010006393A KR 20010006393 A KR20010006393 A KR 20010006393A KR 1019997009480 A KR1019997009480 A KR 1019997009480A KR 19997009480 A KR19997009480 A KR 19997009480A KR 20010006393 A KR20010006393 A KR 20010006393A
- Authority
- KR
- South Korea
- Prior art keywords
- protein
- polynucleotide
- binding
- sequence
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6458397P | 1997-04-16 | 1997-04-16 | |
| US60/064,583 | 1997-04-16 | ||
| PCT/US1998/007462 WO1998046636A2 (en) | 1997-04-16 | 1998-04-14 | β-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20010006393A true KR20010006393A (ko) | 2001-01-26 |
Family
ID=22056941
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019997009480A Ceased KR20010006393A (ko) | 1997-04-16 | 1998-04-14 | β-아밀로이드 펩타이드-결합 단백질 및 이를 암호화하는 폴리뉴클레오타이드 |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0975753A2 (https=) |
| JP (3) | JP2001523093A (https=) |
| KR (1) | KR20010006393A (https=) |
| CN (2) | CN1196785C (https=) |
| AU (1) | AU740445B2 (https=) |
| BR (1) | BR9808562A (https=) |
| CA (1) | CA2286484A1 (https=) |
| EA (1) | EA004256B1 (https=) |
| EE (1) | EE9900482A (https=) |
| GE (1) | GEP20043386B (https=) |
| HU (1) | HUP0003116A3 (https=) |
| ID (1) | ID24914A (https=) |
| IL (3) | IL132236A0 (https=) |
| NO (1) | NO995062L (https=) |
| NZ (1) | NZ500216A (https=) |
| SK (1) | SK143299A3 (https=) |
| UA (1) | UA72875C2 (https=) |
| WO (1) | WO1998046636A2 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7005295B1 (en) | 1997-04-16 | 2006-02-28 | Wyeth | β-amyloid peptide-binding proteins and polynucleotides encoding the same |
| US6787319B2 (en) * | 1997-04-16 | 2004-09-07 | American Home Products Corp. | β-amyloid peptide-binding proteins and polynucleotides encoding the same |
| NZ510997A (en) * | 1998-10-13 | 2004-01-30 | Wyeth Corp | G-protein-coupled receptor-like proteins, polynucleotides encoded by them, and methods of using same |
| US6455082B1 (en) * | 1999-04-26 | 2002-09-24 | Nestec S.A. | Shelf-stable calcium fortified milk and dairy products |
| WO2001029225A1 (en) * | 1999-10-21 | 2001-04-26 | Panorama Research, Inc. | A general method for optimizing the expression of heterologous proteins |
| US8663650B2 (en) | 2003-02-21 | 2014-03-04 | Ac Immune Sa | Methods and compositions comprising supramolecular constructs |
| US7807171B2 (en) | 2003-07-25 | 2010-10-05 | Ac Immune Sa | Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers |
| WO2012020124A1 (en) | 2010-08-12 | 2012-02-16 | Ac Immune S.A. | Vaccine engineering |
| JP6027011B2 (ja) | 2010-10-26 | 2016-11-16 | エーシー イミューン ソシエテ アノニム | 疎水性部分によって修飾されたペプチドを含むリポソームベースの構築物 |
| CN102060912B (zh) * | 2010-11-22 | 2012-11-14 | 清华大学 | 淀粉样蛋白寡聚体构象型抗原表位多肽及其应用 |
| CN111320678B (zh) * | 2020-03-09 | 2023-06-09 | 安亭生物有限责任公司 | 抗菌肽突变体及其应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0332640A1 (en) * | 1986-11-17 | 1989-09-20 | California Biotechnology, Inc. | Recombinant alzheimer's amyloid protein |
| IL115743A0 (en) * | 1994-10-28 | 1996-01-19 | American Nat Red Cross | A mammal with cells containing a transgene and its production |
| US5786180A (en) * | 1995-02-14 | 1998-07-28 | Bayer Corporation | Monoclonal antibody 369.2B specific for β A4 peptide |
-
1998
- 1998-04-14 WO PCT/US1998/007462 patent/WO1998046636A2/en not_active Ceased
- 1998-04-14 IL IL13223698A patent/IL132236A0/xx active IP Right Grant
- 1998-04-14 AU AU71156/98A patent/AU740445B2/en not_active Ceased
- 1998-04-14 EP EP98918186A patent/EP0975753A2/en not_active Withdrawn
- 1998-04-14 ID IDW991187D patent/ID24914A/id unknown
- 1998-04-14 GE GE3744A patent/GEP20043386B/en unknown
- 1998-04-14 UA UA99116193A patent/UA72875C2/uk unknown
- 1998-04-14 SK SK1432-99A patent/SK143299A3/sk unknown
- 1998-04-14 CN CNB988043173A patent/CN1196785C/zh not_active Expired - Fee Related
- 1998-04-14 JP JP54419698A patent/JP2001523093A/ja active Pending
- 1998-04-14 EE EEP199900482A patent/EE9900482A/xx unknown
- 1998-04-14 CA CA002286484A patent/CA2286484A1/en not_active Abandoned
- 1998-04-14 EA EA199900941A patent/EA004256B1/ru not_active IP Right Cessation
- 1998-04-14 HU HU0003116A patent/HUP0003116A3/hu unknown
- 1998-04-14 KR KR1019997009480A patent/KR20010006393A/ko not_active Ceased
- 1998-04-14 BR BR9808562-0A patent/BR9808562A/pt not_active Application Discontinuation
- 1998-04-14 CN CNA200510052975XA patent/CN1690203A/zh active Pending
- 1998-04-14 NZ NZ500216A patent/NZ500216A/xx unknown
-
1999
- 1999-10-06 IL IL132236A patent/IL132236A/en not_active IP Right Cessation
- 1999-10-15 NO NO995062A patent/NO995062L/no not_active Application Discontinuation
-
2006
- 2006-11-05 IL IL179047A patent/IL179047A0/en unknown
-
2007
- 2007-12-28 JP JP2007339660A patent/JP2008104465A/ja active Pending
-
2008
- 2008-06-18 JP JP2008159606A patent/JP2008253275A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN1196785C (zh) | 2005-04-13 |
| NO995062L (no) | 1999-12-14 |
| JP2008104465A (ja) | 2008-05-08 |
| ID24914A (id) | 2000-08-31 |
| HUP0003116A3 (en) | 2003-03-28 |
| CN1268973A (zh) | 2000-10-04 |
| EA199900941A1 (ru) | 2000-06-26 |
| IL132236A0 (en) | 2001-03-19 |
| EE9900482A (https=) | 2000-06-15 |
| EA004256B1 (ru) | 2004-02-26 |
| HUP0003116A2 (hu) | 2001-01-29 |
| BR9808562A (pt) | 2000-05-23 |
| GEP20043386B (en) | 2004-02-10 |
| JP2001523093A (ja) | 2001-11-20 |
| NZ500216A (en) | 2001-06-29 |
| CN1690203A (zh) | 2005-11-02 |
| NO995062D0 (no) | 1999-10-15 |
| JP2008253275A (ja) | 2008-10-23 |
| AU7115698A (en) | 1998-11-11 |
| AU740445B2 (en) | 2001-11-01 |
| IL179047A0 (en) | 2007-03-08 |
| WO1998046636A3 (en) | 1999-01-28 |
| CA2286484A1 (en) | 1998-10-22 |
| SK143299A3 (en) | 2000-09-12 |
| WO1998046636A2 (en) | 1998-10-22 |
| UA72875C2 (uk) | 2005-05-16 |
| IL132236A (en) | 2007-03-08 |
| EP0975753A2 (en) | 2000-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008253275A (ja) | β−アミロイドペプチド結合タンパク質及びそれをコードするポリヌクレオチド | |
| US7101973B2 (en) | β-amyloid peptide-binding proteins and polynucleotides encoding the same | |
| WO2002032286A2 (en) | Protein-protein interactions in neurodegenerative diseases | |
| JP3447301B2 (ja) | 精製SR―p70タンパク質 | |
| JP4314386B2 (ja) | Bcl−2調節因子(BMF)配列及びアポトーシスの調節におけるそれらの使用 | |
| US7005295B1 (en) | β-amyloid peptide-binding proteins and polynucleotides encoding the same | |
| AU769307B2 (en) | G-protein-coupled receptor-like proteins, polynucleotides encoded by them, and methods of using same | |
| CA2319782A1 (en) | Retinoblastoma protein complexes and retinoblastoma interacting proteins | |
| AU768824B2 (en) | DADD, death activator death domain protein | |
| CZ361299A3 (cs) | Proteiny vázající β-amyloidový peptid a polynukleotidy, které je kódují | |
| JPWO2004061102A1 (ja) | 細胞周期調節蛋白質およびその使用 | |
| MXPA00009833A (en) | Dadd, death activator death domain protein | |
| AU2002305397A1 (en) | Beta-amyloid peptide-binding proteins and polynucleotides encoding the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 19991014 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20030411 Comment text: Request for Examination of Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20041223 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20050330 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20041223 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |